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Abstract
Background: Primary progressive aphasia is a language-led dementia, often associated with frontotemporal
dementia. It presents as insidious deterioration of language skills (e.g. naming objects and understanding complex
sentences), with relative sparing of cognitive skills initially. There is little research examining the effectiveness of
communication skills training for primary progressive aphasia, yet speech and language therapists (SLTs) report
regularly using this in clinical practice. ‘Better Conversations with Primary Progressive Aphasia’ has potential to
reduce barriers and increase facilitators to conversation and consequently improve confidence in communication
and quality of life for people living with primary progressive aphasia and their conversation partners. The aim of
this pilot study is to examine the feasibility of running a trial of the ‘Better Conversations with Primary Progressive
Aphasia’ intervention.
Methods: A single blind, randomised controlled pilot study will recruit 42 participants with primary progressive
aphasia and their conversation partners across seven UK National Health Service Trusts. Participants will be
randomised on a 1:1 basis, stratified by site, to receive either the ‘Better Conversations with Primary Progressive
Aphasia’ intervention (21 couples) or no speech and language therapy treatment (21 couples). Participants are
recruited by SLTs who will conduct pre-intervention assessment (week 1) and deliver the intervention (weeks 2 to
5). Junior researchers, who are blinded to allocation, will complete post-intervention measures (week 6). SLTs
complete 9 h of training to prepare them to deliver the intervention. The primary objective of the study is to
establish for a phase III effectiveness study whether the program can be delivered as intended in a UK National
Health Service setting. Specifically, it will establish (1) the acceptability of randomisation, (2) an assessment of
treatment fidelity to determine necessary levels of SLT training, (3) the most appropriate primary outcome measure,
(4) sample size requirements, (5) predicted patient recruitment and retention rates and (6) refined inclusion criteria.
Discussion: Insights from this study will be of relevance to guide development of future research and in particular,
trials of therapeutic interventions in PPA, as well as for clinical care for this population.
Trial registration: Retrospectively registered 28/02/2018 ISRCTN10148247
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Background
The prevalence of dementia is increasing, and it is antici-
pated that by the year 2050, there will be more than 131.5
million living with the diagnosis worldwide [1]. Primary
progressive aphasia (PPA) describes a group of language-
led dementias, often associated with frontotemporal de-
mentia and considered the leading cause of dementia in
people of working age [2, 3]. PPA initially presents solely as
a language difficulty with impairments that superficially
resemble classical stroke aphasia syndromes but worsening
over time. There are three major PPA syndromes, namely
semantic variant that affects the use and understanding of
word meanings, logopenic variant that results in difficulties
in word retrieval, and non-fluent agrammatic variant where
individuals may present with either or both verbal dyspraxia
and grammatical errors [3]. In many cases, other cognitive
deficits (e.g. with memory) may not present for several
years. As a result, people with PPA are often highly moti-
vated to seek speech and language therapy. Perhaps, as a re-
sult of this retained awareness, people with PPA are prone
to low self-esteem and poor confidence [4].
The research evidence for speech and language therapy
interventions for PPA is sparse and is predominantly lim-
ited to naming therapies, word finding difficulty being a
common impairment [5–11]. However, naming is often
not the main limitation on communication function in
PPA, and interventions are required to address real world
communication function. This is particularly relevant
given that prognosis in PPA is for loss of function, rather
than improvement as in stroke aphasia, and there is a
need to engage family/carers in speech and language ther-
apy. Yet, there is a paucity of literature examining the im-
pact that speech and language therapists (SLTs) can have
in supporting a person with PPA and their family/carers
with conversation [12, 13]. Nevertheless, SLTs in clinical
practice report using communication training programs
more often than naming therapies [14]. This is not sur-
prising when reports suggest many patients disengage
from naming therapies due to the frustration of practising
individual words they will inevitably lose as the disease
progresses [2].
SLTs have been reported to prioritise working on com-
munication between people with PPA and their conversa-
tion partners (CPs), specifically targeting the use of
meaningful strategies for both the person and their family
members [15] using a variety of communication training
approaches from the stroke and brain injury literature that
have not been trialled for PPA [16]. Communication skills
training has a growing evidence base in these fields [17, 18].
Programs have in common individualised feedback (often
video-based) on facilitators (behaviours that help conversa-
tion such as using multi-modal communication—speaking,
gesture, drawing and other communication aids) and bar-
riers (behaviours that create problems in conversation such
as the use of ‘test’ questions, asked by the CP despite
already knowing the answer) to communication,
followed by strategy training, with the aim of maximis-
ing the success of everyday conversations [19]. Whilst
many such programs focus on training the CP only,
Better Conversations with Aphasia (BCA) [20] aims to
change the conversation skills of both a person with
post-stroke aphasia and a CP [21–23]. BCA is a free
online package consisting of a therapy manual and
training materials for SLTs. Since its launch in 2013, it
has attracted over 5000 users worldwide. BCA utilises
video feedback to enable participants to reflect on com-
munication facilitators and barriers, and the authors
believe this to be a key mediator for improved conver-
sation skill. In a UK-wide survey, a high proportion of
SLTs report working with both the person with PPA
and their CP and using BCA as a tool to support this
therapy above other tools that only target the CP [16],
thus motivating BCA as a target for adaptation to PPA
over other possible alternative stroke aphasia programs.
In summary, the evidence base for communication
training in PPA is limited, yet front-line SLTs favour this
over naming programs with a stronger evidence base. This
is because SLTs identify the need to support both a person
with PPA and their CPs, who are equally distressed about
conversation breakdown. We presently lack evidence to
guide effective communication-based interventions in
PPA. In response to this gap in the evidence base, the au-
thors undertook a research study to develop and pilot a
communication skills training program for people with
PPA and their CPs. The BCA program for post-stroke
aphasia was initially adapted to meet the needs of people
with PPA using data collected from a UK-wide survey of
speech and language therapy practice [16] and a system-
atic review of the research literature on functional com-
munication focused interventions for people with PPA
and their families [24]. It was further refined with SLTs
who participated in a process using a nominal group con-
sensus technique [25] to agree with the intervention ob-
jectives and with people with PPA and their families who
took part in a series of focus groups. A BCPPA steering
group (of people with PPA, their family members and ex-
pert professionals) was established at the start of the work
to provide advice and feedback on all aspects of study
management, including the co-production of materials for
the program and support for future dissemination of re-
sults. In terms of the MRC guidance on development and
evaluation of complex interventions [26], intervention re-
finement constituted phase I work to fully define BCPPA.
This paper summarises the phase II randomised con-
trolled pilot study protocol for the BCPPA program. Our
UK-wide survey of SLTs [16] shows that there is no stand-
ard speech and language treatment for people with PPA,
thus it is not possible to have a usual care group for the
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study. Instead, a no speech and language therapy treat-
ment control group has been used. The protocol has
followed the CONSORT (Consolidated Standards of
Reporting Trials) guidelines and the SPIRIT (Standard
Protocol Items: Recommendations for Interventional
Trials) statement [27] as well as the TIDieR (Template
for Intervention Description and Replication) checklist
and guide [28].
Aim
The primary aim of this study is to pilot the BCPPA pro-
gram compared to a no speech and language therapy treat-
ment control group over participating sites to establish for
a main trial whether BCPPA can be delivered as intended
in an NHS setting. Specifically, the aim of piloting the
BCPPA program compared to a no speech and language
therapy treatment control group is to establish:
 The acceptability of randomisation
 An assessment of BCPPA treatment fidelity to
determine necessary levels of SLT training
 The most appropriate primary outcome measure
 Sample size calculation
 Predicted patient recruitment and retention rates
 Refined inclusion criteria
Methods
Design
This is a single blind, randomised controlled pilot
study with BCPPA treatment versus no speech and
language therapy treatment. Participants will be in-
volved for a total of 6 weeks: pre-intervention mea-
sures (week 1); intervention/control (weeks 2–5); and
post-intervention measures (week 6). See Fig. 1 for
participant flow chart through study.
Setting
The seven participating NHS sites are located in England.
Local collaborators (SLTs) at these sites will recruit partici-
pants, obtain consent, complete pre-intervention measures
and deliver the BCPPA intervention across outpatient and
community settings over a 20-month period.
Population
The study includes adults (> 18 years) with a diagnosis
or potential diagnosis of PPA (in view of the difficult
and often protracted diagnostic process). See Table 1 for
inclusion and exclusion criteria.
Identification and recruitment of participants
Local collaborators will be asked to identify people re-
ferred to their service who are suitable for the pilot using
Fig. 1 BCPPA participant flowchart through study
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the inclusion and exclusion criteria (Table 1) and invite
them to participate. Local collaborators will complete a
log to record the number of people with a diagnosis of
PPA who do not meet the inclusion criteria, they will also
record the number of people who are eligible but who
have declined to participate in the study and their reasons
why if provided. People who meet the inclusion criteria
will not be under any obligation to take part in this re-
search and this will be made clear from the outset. Poten-
tial participants will be provided with a participant
information sheet (see Additional file 1) before informed
consent is obtained at least 48 h later (see Fig. 2 for con-
sent flowchart).
All participants in the study will be in the mild to mod-
erate stages of PPA and therefore would generally be ex-
pected to be competent to give informed consent to
participate, provided that appropriate care is taken to ex-
plain the research and sufficient time is allowed for them
to reach a decision. Due to the brief nature of the partici-
pants’ involvement in the study (5 weeks) it is not antici-
pated that decision-making capacity will change over this
time; however, this will be monitored by the local collab-
orator who obtains consent following the Mental Capacity
Act (MCA) [29], Royal College of Speech and Language
Therapists (RCSLT) guidelines [30] and Good Clinical
Practice Standards [31]. The local collaborators are spe-
cialist SLTs with considerable experience of supporting in-
dividuals with communication and cognitive impairment
and who complete annual mandatory training on the
MCA [29] and issues related to obtaining consent. If a
local collaborator has any doubts regarding the capacity of
a person with PPA to provide informed consent for this
study, advice will be sought from the first author or an ap-
propriate professional involved in their care, e.g. the GP,
as is standard practice. Participant information sheets and
consent forms (see the Additional files) have been
designed to be dementia friendly [32] and modified with
advice from the study’s steering group of people with PPA
and their carers (Additional file 2).
Randomisation
Randomisation will be conducted by the final author
using a random number generator and stratified by
site using blocks of four to balance across BCPPA
treatment and no speech and language therapy treat-
ment groups within each site. Block sizes will not be
disclosed to local collaborators. Local collaborators
will be informed of participant group allocation via
email after pre-assessment has been completed.
Blinding
Post-intervention measures will be administered by a pair
of junior researchers (student SLTs at UCL) with skills in
the assessment of people with PPA but crucially blinded
to group allocation. Participants and family members will
be asked not to reveal their allocation during the
post-assessment session. They will be reminded of this
prior to their appointment, by letter and verbally, at the
start of the session. Should the students become un-
blinded during the reassessment process, this will be doc-
umented and the reasons recorded.
Sample size justification
As there are no data available to estimate a sample size, the
recruitment of participants has been dealt with pragmatic-
ally. Based on discussion with clinicians at the primary re-
search site, it is estimated that it will be possible to recruit
42 participants over an 18-month period at seven sites. This
pilot will provide information on recruitment and retention
and facilitate a sample size calculation for a future full trial.
Recruitment will be reviewed at 2-month intervals during
the study, and the recruitment strategy will be amended as
necessary to achieve the target number.
Pre- and post-intervention measures
Participants will complete pre-intervention language, com-
munication and quality of life measures (see Table 2) with
the local collaborator in week 1 of the study. Completing
assessment to gain an insight into areas of communication
Table 1 Inclusion and exclusion criteria for potential
participants
Inclusion criteria Local collaborators at participating NHS sites
will judge potential participants against the
following criteria:
(a) Have a diagnosis or possible diagnosis
of PPA
(b) Have some ability to communicate and
understand communication in order to
participate in the BCPPA program;
(c) Are able to see and hear well enough to
participate in the BCPPA program
(d) Are functionally able to engage in the
BCPPA program (i.e. able to maintain some
concentration and remain in a 60–90 min
session, minimal challenging behaviour that
would be unlikely to cause disruption)
(e) English as their language of daily use;
(f) Have a conversation partner (CP) who is
able to and consents to participating in
the project.
Exclusion criteria People will be excluded from participation
in the pilot if they:
(a) Have a history of brain lesions or major
head trauma;
(b) Have major physical illness or disability
which could impact on participation;
(c) Present with a major psychiatric diagnosis;
(d) Present with prominent behavioural
disturbance;
(e) Present with prominent episodic memory,
visual memory, or visuoperceptual impairments.
Note: The researchers acknowledge that the inclusion criteria may result in
significant heterogeneity across participants—please refer to discussion
of limitations
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strength and difficulty prior to commencing intervention is
routine procedure in speech and language therapy practice,
and importantly, provides the opportunity for local collabo-
rators to build rapport with participants before delivery of
the intervention. All measures will be repeated after inter-
vention at week 6 by a pair of junior researchers. In order
to collect communication data, participants will be trained
to independently use an iPad to video record conversation
samples. A conversation topic list will be provided to sup-
port this process should they require it. Table 3 summarises
the schedule of pre- and post-intervention measures.
Description of the intervention
BCPPA program
BCPPA provides a protocol for SLTs to deliver a four-ses-
sion communication training program for people with PPA
and their CPs. Participant's pre-intervention video-recorded
conversation samples will be used to provide clips for video
feedback during intervention sessions. The manual is made
available to local collaborators online. The intervention is
described in detail in Additional file 1, using the TIDieR
checklist [28].
No speech and language therapy treatment
Those participants assigned to a no speech and language
therapy treatment condition will receive usual healthcare
provision (anticipated to include neurology, GP reviews,
and allied health input such as physiotherapy). However,
this will exclude speech and language therapy intervention
for the duration of their participation in the study. The
period of no speech and language therapy treatment will
be 5 weeks – 4 weeks when the treatment group will re-
ceive BCPPA and 1 week when all participants complete
post-intervention measures. As there is no critical period
for treatment delivery for people with PPA, after this brief
period, the participants allocated to the no speech and
language therapy treatment group will resume all aspects
of local speech and language therapy provision without
further interruption.
Fig. 2 Consent flowchart
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Training of local collaborators
Local collaborators will be trained to deliver the BCPPA
program by the first author and will be provided with a
training package including all required materials. Table 4
presents an overview of training content.
Assessment of treatment fidelity
In order to ensure treatment fidelity, each local collabora-
tor’s sessions with their first participant will be observed by
the first author (via remote viewing of a video recording)
and feedback will be provided over Skype or by telephone.
After that, telephone and email support will occur as
needed, to ensure knowledge and skills are maintained. In
addition, to ensure adherence is maintained, local collabo-
rators will be asked to audio record the intervention ses-
sions with all participants. A random sample of 10% of
recordings will be analysed using a treatment adherence
checklist by two independent raters to permit an investiga-
tion of inter-rater reliability. A further 10% of this random
sample will be analysed by a second rater, and any differ-
ences will be discussed and agreed. Local collaborators will
also be asked to reflect on adherence by completing an
adherence questionnaire and by documenting session
length and tasks completed. These will be anonym-
ously returned to the first author in pre-stamped ad-
dressed envelopes.
Assessment of acceptability of the intervention
In order to ensure the treatment is acceptable to people
with PPA, their CPs and local collaborators, each will be
asked to provide feedback on the intervention. Access-
ible feedback forms will be given to participants with
PPA and their CPs at every intervention session, to be
completed and returned anonymously in pre-stamped
addressed envelopes directly to the first author. Add-
itionally, local collaborators will be asked to include
feedback on acceptability as part of the adherence ques-
tionnaire, completed after every session.
Data management
All personal information such as date of diagnosis, rele-
vant medical and social history will remain confidential.
Participants will be given a unique number which will
be used on paperwork, assessment score sheets and in
the names of all video files, and in all subsequent ana-
lysis documents and publications. Lists of participant
names and their unique numbers (required to conduct
the remote randomisation procedure) will be kept by a
designated local collaborator in a locked cabinet at each
NHS site. Each list will only contain the names of par-
ticipants based at the relevant site.
Participants will consent to be video recorded in conver-
sation for the purposes of outcome measurement and to
provide clips for video feedback during intervention ses-
sions. Participants’ faces will be fully visible in these video
recordings as people’s expressions form a significant part
of natural human communication, the focus of the inter-
vention being piloted. Confidentiality can be guaranteed
in the sharing of this footage at conferences and during
teaching activities but not anonymity. Judicious selection
of recordings will minimise this risk (e.g. footage where
personal details are discussed will not be used, and names
will be blanked out of the audio stream). Allied health
professionals viewing this footage are bound by profes-
sional codes of ethics requiring them to maintain client
confidentiality. Participants (and their CPs) will be asked
whether they are willing to accept the possibility of being
recognised, and can opt out of this use of their data whilst
remaining part of the study. Only the research team
Table 2 List of pre- and post-intervention measures
Language measures:
1. Comprehensive Aphasia Test [43]
This language battery provides a profile of performance across all
modalities of language production and comprehension.
Communication measure:
1. Video recordings of conversation samples
This informal measure adapted from the Aphasia Conversation Measure
[21] identifies barriers and facilitators to conversation between the
person with PPA and their CP and assesses changes in conversation
after intervention
Quality of life measures:
1. Dementia Quality of Life Measure [44]
This questionnaire is designed to ask people with dementia to rate their
quality of life across the three main domains of feelings, memory and
everyday life.
2. The Aphasia Impact Questionnaire [45]
A tool designed to measure the impact of living with aphasia across
three domains of communication, participation and emotional
well-being.
3. Communication Confidence Rating Scale for Aphasia [42]
This is a questionnaire of communication confidence that uses a
self-rating scale designed for people with aphasia.
4. Perceived Stress Scale [46] (completed by CP only)
This is a self-report questionnaire for measuring the respondent’s
perception of stress.
5. Zarit burden interview [47] (completed by CP only)
This is a caregiver self-report questionnaire for measuring personal and
care strain.
Table 3 Schedule of pre- and post-intervention measures
Consent session Preintervention assessment
(1 week)
Treatment/control
(4 weeks)
Postintervention assessment
(1 week)
Final data collection
Week 0 1 2 3 4 5 6 7
Conversation 1a 2i 3i 4a 5a 6i 7i 8i
Conversation video recording: a, assessor present but not in room; i, independent home recording
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members will have access to the entire video recorded
data set. All transcripts of conversation data will be anon-
ymised by the use of pseudonyms for all named people
and places.
No data management committee will be established as it
is felt that this short, small-scale pilot carries minimal
risks. The study is compliant with General Data Protec-
tion Regulations. If information disclosed by any partici-
pant leads the first author to believe that a participant is at
risk of harm or harming others, confidentiality will be
broken to ensure safety.
Data analysis
Analysis for this single blind, randomised controlled pilot
study will involve both quantitative and qualitative
methods. Language and quality of life assessment data will
be entered into a database and analysed using the Statis-
tical Package for the Social Sciences [33]. All data will be
explored to test for assumptions of normalcy. If assump-
tions are not met, appropriate non-parametric tests will
be used. Repeated measures ANOVA will be used in the
analysis with group (no speech and language therapy
treatment, BCPPA treatment) as a between subject factor
and time (pre-therapy and post-therapy) as a within sub-
ject factor. This information will be used to determine a
suitable sensitive outcome measure and to perform a
power calculation to determine sample size for a fully
powered trial. Conversation data will be analysed follow-
ing a procedure developed for the BCA intervention [21]
to identify change in the use of targeted strategies follow-
ing intervention. This will involve counting barrier and fa-
cilitator behaviours in 5-min video samples selected from
the pre- and post-intervention conversation samples.
These counts will be analysed using Poisson Trend Test
suitable for observations occurring in Poisson distribution.
All pre-therapy conversations will be weighted the same
as one another, as will all the post therapy conversations.
Outcomes for different participants will be investigated
using a Test for Homogeneity, where this is significant,
and the effect for different dyads will be calculated using
the Holm-Bonferroni procedure.
Descriptive statistics will be used to report recruit-
ment, attendance, attrition, and reasons for dropout. A
CONSORT (Consolidated Standards of Reporting Tri-
als) and SPIRIT (Standard Protocol Items: Recommen-
dations for Interventional Trials) [27] flow chart will be
used to present overall recruitment to and progression
through the study (Fig. 1). Recruitment and retention
rates will be used to support sample size calculations to
inform a future full trial and plan the required number
of sites to meet this target. Adverse events will also be
recorded, and participant feedback forms examined to
inform future recruitment procedures. Stroke-related
aphasia trials in the UK NHS have reported recruitment
rates of between 38 and 44% from potential participants
at the research sites [34–36].
Analysis of fidelity and adherence data will inform fu-
ture training needs. Although fidelity data is sparse for
speech and language intervention trials, processes such
as those deployed in our study have been shown to
achieve an average of 80–100% fidelity [37–39]. Thus,
we have selected 80% as the minimum target for fidel-
ity. Acceptability of the intervention will be considered,
based on analysis of the participant feedback forms and
adherence data to inform further refinements of the
intervention prior to a future full trial. Analysis of par-
ticipant feedback and adherence data will use descrip-
tive statistics. For open-ended questions or ‘other’
response categories, qualitative analysis will be used,
specifically identifying themes and sub-themes using
thematic analysis [40].
Criteria for success
This study will be considered appropriate to proceed to
a full trial if:
Patients and local collaborators report generally
positive views about acceptability of randomisation and
Table 4 Overview of training of local collaborators (SLTs)
Training goals
For local collaborators to be able to:
• Identify potential participants who meet the study inclusion criteria
• Consent participants to the study
• Deliver the BCPPA program
• Complete pre-intervention measures
• Complete fidelity measures
• Access the support and advice of the researcher (first author)
throughout the study
Pre-training work
• Pre-reading materials from the Study Training Pack to support
participant identification, completion of outcome measures and
delivery of intervention
Day 1. (4.5 h)
• Overview study procedures.
• Discuss inclusion/exclusion criteria with vignettes to problem solve
• Discuss consent procedures and flow chart with accompanying case
study.
• Discuss purpose and process of video recording conversation
samples as outcome measure and to support therapy
• Practice video recording for conversation samples.
• Observe sample video recordings and identify barriers and facilitators
to conversation with a view to planning therapy
Day 2. (4.5 h)
• Discuss and practice completing remaining outcome measures
• Discuss therapy sessions with practical role play tasks, practice
completing session plans, and observe sample video recordings
demonstrating delivery of intervention, including goal setting and
having emotional conversations.
• Discuss fidelity measures (video recordings, local collaborator
adherence questionnaire, and participant feedback questionnaires)
• Provide contact information for ongoing support
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of intervention as determined by evaluation of feedback
forms;
A suitable sensitive outcome measure is determined
and sample size estimated;
Local collaborator intervention-fidelity rate is at least
80%.
Assessment and management of risk
This is a low-risk study. It is possible that participants
will not experience improvements as a result of the
intervention. However, there is evidence to suggest
that such interventions are effective for improving
communication and well-being in adults with non-
progressive aphasia and their carers [14]. Importantly,
there is no evidence to indicate that participants will
experience any harmful effects. Most of the measures
used in this study are frequently used in routine clin-
ical practice with people with PPA. Additionally, the
local collaborators are SLTs with skills to complete
measures in a sensitive and supportive manner, mini-
mising risk of distress. If participants do not feel emo-
tionally or physically well enough to continue, then an
assessment will be postponed. Video recording of con-
versations might also cause distress. To minimise the
risk, we will ensure that as far as possible, the partici-
pants are familiarised with recording devices and
understand why video recording is necessary. All pro-
cedures are set out within our participant information
sheets (see Additional file 1) and consent forms, which
were co-produced with the study steering group of
people with PPA and their carers. Participants will be
reminded that they can withdraw from the study at
any time without giving a reason. Any adverse events
will be recorded in the participant’s medical record,
and the study sponsor informed.
Discussion
To the best of our knowledge, this is the first randomised
controlled UK pilot study of a conversation training inter-
vention for people with PPA and their families. It will in-
form the feasibility of delivering a future full randomised
controlled trial investigating the effectiveness of the
BCPPA program in an NHS setting. There is little docu-
mented evidence of the impact of communication training
for people with PPA and their CPs, yet there are reports of
its widespread clinical use by SLTs across the UK [15, 16].
As in prior functional communication-focused PPA inter-
vention studies [41], BCPPA might improve subjective
confidence in communication (using the Communication
Confidence Rating Scale in Aphasia [42] see Table 2 list of
pre- and post- intervention measures) even if there is no
clear impact on specific language measures, as well as po-
tentially improving carer wellbeing. Thus, insights from
this study will be of relevance to guide development of
future research and in particular, trials of therapeutic in-
terventions in PPA, as well as for clinical care for this
population. The paucity of literature on functional
communication-focused interventions for people with
PPA makes the findings of interest to dementia re-
searchers and SLTs, as well as people with PPA and their
family members. The study will generate a unique dataset
of language, conversation, and quality of life measures
from people living with PPA and family members. It will
lead to the identification of sensitive measures of the im-
pact of functional communication-focused interventions
for PPA. Additionally, the study will provide a rich source
of information on acceptability of the BCPPA program to
people with PPA and their CPs. Importantly, this study in-
volves people with PPA and their families, and a group of
expert SLTs, in the development of a manualised interven-
tion program that meets their communication needs.
Study limitations include the inability to blind partici-
pants to group allocation, a common barrier in behav-
ioural studies. Those allocated to the control group will
not receive any intervention for 4 weeks as there is no
comparable standard care intervention. Similarly, it is
not possible to blind local collaborators delivering the
intervention. For this reason, post-intervention assess-
ment is not completed by the local collaborators but by
pairs of junior researchers who will be blinded to group
allocation. The inclusion criteria for this study may re-
sult in significant heterogeneity across participants in
terms of language profile and communication difficul-
ties, making it difficult to compare participants’ skills
pre and post intervention. Thus, a range of outcome
measures are being piloted across language, communi-
cation, and quality of life to identify the most sensitive
across all participants. BCPPA is designed to be tailored
to an individual’s needs, which may result in variation
in the types of strategies identified and practiced. To
counter this, the key components of BCPPA remain
fixed, and measures of fidelity will demonstrate the
consistency with which the intervention in delivered. A
further potential limitation is ascertainment bias since
access to speech and language therapy for PPA varies
widely across the UK, and some of the likely barriers to
access (socio-economic, cultural, linguistic, etc.) could
also influence BCPPA outcomes. Despite these limita-
tions, this study represents an important step toward a
future full-scale RCT to determine the effectiveness of
BCPPA for people with PPA and their family members.
The results of this study will be disseminated via presenta-
tions at national and international conferences and submit-
ted for publication in peer reviewed scientific journals. In
the medium term, the BCPPA program and training mate-
rials will be made available to SLTs via UCL’s public
e-learning platform, alongside BCA [18]. With support from
the study steering committee, results will be disseminated
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through professional and user group networks via publica-
tions and presentations, for example, at the PPA support
group branch of the Rare Dementias Support Group based
at UCL (http://www.raredementiasupport.org/).
Trial status
Trial registration number ISRCTN10148247. Recruit-
ment commenced in November 2017 and is due to end
in March 2019.
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Additional file 2: Participant information sheet. (DOCX 2194 kb)
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